Filter
258
Filtered Results: 258
Text search:
Uganda
Aids
Commission,
Republic
of
Uganda
Featured
Recommendations
18
New Publications
68
Language
Document type
No document type
186
Studies & Reports
50
Guidelines
12
Strategic & Response Plan
7
Manuals
3
Countries / Regions
Uganda
33
Africa
15
Kenya
10
Rwanda
10
Tanzania
9
Ethiopia
7
Zambia
7
South Africa
7
Malawi
7
Liberia
5
Nigeria
5
South Sudan
5
Namibia
5
East and Southern Africa
5
Global
5
Sierra Leone
4
Congo, Democratic Republic of
3
Ghana
3
Zimbabwe
3
Germany
3
West and Central Africa
3
India
2
Nepal
2
Mozambique
2
Lesotho
2
Guinea
1
Burkina Faso
1
Mali
1
Haiti
1
Cambodia
1
Indonesia
1
Bangladesh
1
Sudan
1
Eswatini/ Swaziland
1
Ukraine
1
Botswana
1
Angola
1
Middle East and North Africa
1
Latin America and the Carribbean
1
Western and Central Europe
1
Authors & Publishers
Publication Years
Category
Countries
89
Public Health
18
Women & Child Health
12
Clinical Guidelines
10
Key Resources
2
Pharmacy & Technologies
2
Capacity Building
1
Toolboxes
HIV
58
Mental Health
23
Disability
19
COVID-19
12
Global Health Education
10
Ebola
8
TB
7
Caregiver
7
Rapid Response
6
NTDs
5
Health Financing Toolbox
5
Conflict
4
Refugee
4
Pharmacy
4
Planetary Health
3
NCDs
2
AMR
1
Social Ethics
1
Cancer in sub-Saharan Africa
recommended
Lancet Oncol 2022; 23: e251–312Published OnlineMay 9, 2022 https://doi.org/10.1016/S1470-2045(21)00720-8
In sub-Saharan Africa (SSA), urgent action is needed to curb a growing crisis in cancer incidence and mortality.
Without rapid interventions, data estimates show a major increase in cancer mo...
The 2014–2015 Ebola epidemic in western Africa was the longest and most deadly Ebola epidemic in history, resulting in 28,616 cases and 11,310 deaths in Guinea, Liberia, and Sierra Leone. The Ebola virus has been known since 1976, when two separate outbreaks were identified in the Democratic ... of Congo (then Zaire) and South Sudan (then Sudan). However, because all Ebola outbreaks prior to that in West Africa in 2014–2015 were relatively isolated and of short duration, little was known about how to best manage patients to improve survival, and there were no approved therapeutics or vaccines. When the World Heath Organization declared the 2014-2015 epidemic a public health emergency of international concern in August 2014, several teams began conducting formal clinical trials in the Ebola affected countries during the outbreak.
Circulating vaccine-derived poliovirus type 2 in Angola
Ebola virus disease in Democratic Republic of the Congo
Dengue fever in Côte d’Ivoire
Humanitarian crisis in north-east ...
Getting on track to end AIDS as a public health threat by 2030. This new Road Map charts a way forward for country-level actions to achieve an ambitious set of HIV prevention targets by 2025. Those ...
It provides insight into WHO’s work that aims to improve the health of the people of the United Republic ... Tanzania in collaboration with key stakeholders.
Lessons and best practices in empowering pastoralist communities to prevent HIV infection and reduce the impact of AIDS in Ethiopia. Briefing Paper
The government of Rwanda conducted the 2010 Rwanda Demographic and Health Survey (RDHS) to gather up-to-date information for monitoring progress on healthcare programs and policies in Rwanda, including the Economic Development and Poverty Reduction ...
This publication marks the 25th anniversary of the Beijing Declaration and Platform for Action. It is dedicated to the women leaders and allied community mobilizers who have devoted their lives to advancing the human rights and dignity ... all people affected by the HIV epidemic, and to opposing social injustice, gender inequality, stigma and discrimination, and violence. Unless otherwise indicated, the HIV-related statistics cited in this publication reflect the most recent UNAIDS data available.
July 2018
This fourth edition of the Unitaid/WHO market and technology landscape: HIV rapid diagnostic tests for self-testing report summarizes the current HIV testing gap; the challenges facing efforts to scale up; and the potential role HIV se...
The COVID-19 pandemic has exposed the inadequacy of investments in public health, the persistence of profound economic and social inequalities and the fragility ... many key global systems and approaches.
The report provides a brief introduction to patents and licences and their effect on the market for antiretroviral (ARV) medicines. It gives an overview of the patent landscape with respect to a select number ... ARV medicines in developing countries as of April 2014. The focus is primarily on those ARVs that are recommended by the World Health Organization (WHO) as well as new ARVs that have either recently obtained regulatory approval or are in phase III clinical trials.
This report explores the extent to which evidence, policy, normative guidance and commitments on HIV and gender-based violence, and their interlinkages, is being translated into action on the ground in fragile settings. These issues are explored through the lens ... training of peace support operations deploying African troops across Africa and beyond.
This report is one of the first major products of the newly established Precision Public Health Metrics unit of the UCN cluster ... the WHO Regional Office for Africa. The report presents national trends in communicable and non-communicable disease burden and control in the WHO African region. It tracks progress made with respect to disease burden reduction, elimination and eradication. It also highlights major emerging threats, opportunities and priorities in the fight against commu- nicable and non-communicable diseases in the region. It covers the period 2000-2022, but for some indicators, information is available only up to 2021.
The report shows the number of reported cases for malaria and vaccine preventable diseases (meningitis, measles, yellow fever, pertussis, diphtheria, tetanus, and polio); disease incidence due to HIV, tuberculosis and four major noncommunicable diseases (cardiovas- cular diseases, cancers, diabetes and chronic respira- tory diseases).
Bull World Health Organ 2015;93:457–467 | doi: http://dx.doi.org/10.2471/BLT.14.147215
UNAIDS | 2016–2021 Strategy
Accessed: 20.11.2019
